ITGB1 was identified as an independent prognostic integrin marker associated with OS in NSCLC, which provided important clues to understanding the molecular mechanism of metastasis and contributing to the therapeutic treatment of lung cancer [20–23]. This evidence concerns the gene ITGB1 and lung carcinoma.